Skip to content

Other Investing at other companies

NNN REIT logo
NNN REITNNN
$347K+83.6%
Repligen logo
RepligenRGEN
$416K
ST
Sensata TechnologiesST
-$1.4M-1,300%
CHE
ChemedCHE
$197K-29.9%
LKQ logo
LKQLKQ
-$3M+25.0%
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$0

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's other investing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's other investing?
Indivior Pharmaceuticals, Inc. (INDV) reported other investing of $0 in Q4 2025.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's other investing?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's other investing has grown at a -100.0% compound annual growth rate (CAGR), from -$1M to $0.
What does other investing mean?
Miscellaneous investing cash flows not classified in specific line items.